TMC Life Sciences

TMCLIFE

MYQ0101OO004

Healthcare Facilities & Services

End-of-day quote BURSA MALAYSIA Other stock markets 18:00:00 2024-07-15 EDT			5-day change	1st Jan Change
0.655 ^MYR	-0.76%		0.00%	-8.39%

05-24	TMC Life Sciences’ Attributable Profit for Fiscal Q3 Shrinks	MT
05-23	TMC Life Sciences Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	CI

TMC Life Sciences Berhad Appoints Wilson Sam as Executive Alternate Director, Effective February 1, 2019

January 24, 2019 at 02:43 am

TMC Life Sciences Berhad appointed Mr. Wilson Sam as Executive Alternate Director, effective February 1, 2019. He is currently the Senior Vice President of Kestrel Capital Pte. Ltd.

Latest news about TMC Life Sciences

TMC Life Sciences’ Attributable Profit for Fiscal Q3 Shrinks	05-24	MT
TMC Life Sciences Berhad Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	05-23	CI
TMC Life Sciences Unit, Oncocare Medical Extend Term of LOI	05-22	MT
TMC Life Sciences' Profit More Than Doubles in Fiscal Q2	02-04	MT
TMC Life Sciences Berhad Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023	02-02	CI
TMC Life Sciences Suspends Group CEO	01-29	MT
TMC Life Sciences Berhad Announces Suspension of Puan Wan Nadiah Binti Wan Mohd Abdullah Yaakob as Group Chief Executive Officer	01-29	CI
TMC Life Sciences Berhad Announces Redesignation of Dr Heng Jun Li Melvin from Non Executive Director to Group Chief Executive Officer	01-29	CI
TMC Life Sciences' Profit, Revenue Rise in Fiscal Q1	11-15	MT
TMC Life Sciences Berhad Reports Earnings Results for the First Quarter Ended September 30, 2023	11-14	CI
TMC Life Sciences Berhad Announces CFO Changes	11-09	CI
TMC Life Sciences Berhad Announces Redesignation of Kan Kheong Ng as Executive Vice Chairman	11-09	CI
Tmc Life Sciences Berhad Proposes Single-Tier Final Dividend Per Ordinary Share for the Financial Year Ended 30 June 2023, Payable on 03 January 2024	23-08-22	CI
TMC Life Sciences Berhad Reports Earnings Results for the Fourth Quarter and Full Year Ended June 30, 2023	23-08-22	CI
Tmc Life Sciences Berhad Proposes Special Single-Tier Dividend, Payable on 03 January 2024	23-08-22	CI
Tmc Life Sciences Berhad Announces Appointment of Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Risk Committee	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment of Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Nomination Committee	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Remuneration Committee	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment of Dato' Mohd Sheridan Bin Ramli as Independent and Non Executive Director	23-07-14	CI
Tmc Life Sciences Berhad Announces Appointment of Dato' Mohd Sheridan Bin Ramli as Independent and Non Executive Member of Audit Committee	23-07-14	CI
TMC Life Sciences Berhad Announces Redesignation of Cheah Ho Chee as Independent and Non Executive Chairman of Risk Committee from Member of Risk Committee	23-05-31	CI
TMC Life Sciences Berhad Announces Resignation of Gary Ho Kuat Foong as Independent and Non Executive Independent Director	23-05-31	CI
TMC Life Sciences Berhad Announces Appointment of Puan Mazrina Binti Arifin as Independent and Non Executive Member of Risk Committee	23-05-31	CI
TMC Life Sciences Berhad Announces Cessation of Office of Gary Ho Kuat Foong as Independent and Non Executive Member of Risk Committee	23-05-31	CI
Tmc Life Sciences Berhad Announces Resignation of Datin Sri Claire Lee Suk Leng as Independent and Non Executive Independent Director	23-05-31	CI

TMC Life Sciences Berhad is a Malaysia-based investment holding company. The Companyâs segments include Thomson Hospitals Sdn. Bhd., IVF Technologies Sdn. Bhd., TMC Lifestyle Sdn. Bhd., TMC Properties Sdn. Bhd., Thomson TCM Sdn. Bhd., BB Waterfront Sdn. Bhd., TMC Care Sdn. Bhd. and others. Thomson Hospitals Sdn. Bhd provides multi-disciplinary tertiary care services. IVF Technologies Sdn. Bhd. provides fertility services and operation of womenâs clinic. TMC Lifestyle Sdn. Bhd. is engaged in the development, marketing and management of healthcare programs, and provision of fertility consultancy, laboratory and embryology services and research and development. TMC Properties Sdn. Bhd. is involved in property investment. Thomson TCM Sdn. Bhd. is involved in the provision of traditional and complementary services. BB Waterfront Sdn. Bhd. is involved in the provision of healthcare services. TMC Care Sdn. Bhd. offers pharmacy services and products, and management support services.

Sector

Healthcare Facilities & Services

Calendar

2024-08-19 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Hospitals, Clinics & Primary Care Services

	1st Jan change	Capi.
TMC LIFE SCIENCES	-8.39%	246M
AIER EYE HOSPITAL GROUP CO., LTD.	-33.38%	13.43B
IHH HEALTHCARE	+5.31%	11.95B
BANGKOK DUSIT MEDICAL SERVICES	-4.50%	11.66B
APOLLO HOSPITALS ENTERPRISE LIMITED	+13.14%	11.08B
ENCOMPASS HEALTH CORPORATION	+30.61%	8.61B
THE ENSIGN GROUP, INC.	+24.64%	7.63B
MOUWASAT MEDICAL SERVICES COMPANY	+8.05%	6.45B
FORTIS HEALTHCARE LIMITED	+16.63%	4.39B
DALLAH HEALTHCARE COMPANY	-7.45%	4.11B